Dendritic cell based cancer vaccine for immunotherapy of Cancer- research studies and their results for doctors
We provide autologous Dendritic cell based vaccine
1. Types of Treatment of Cancer which are recognised by American Cancer Society.
http://www.cancer.org/docroot/ETO/ETO_1.asp?sitearea=ETO
2. What is immunotherapy of cancer:
http://www.cancer.org/docroot/ETO/eto_1_3_Immunotherapy.asp
Types of immunotherapies: http://www.cancer.org/docroot/ETO/content/ETO_1_4X_Types_of_Immunotherapy.asp?sitearea=ETO
3. Cancer vaccines:
4. Cancer therapy with immature monocyte-derived dendritic cells in patients with advanced breast cancer
Conclusions: We show that dendritic cell based immunotherapy can produce durable tumor response even in advanced breast cancer.
5. ITL cancer clinic , Bahamas, relies mainly on cancer vaccines to stimulate a patient's own immune system to recognize and destroy tumor cells.
http://www.immunemedicine.com/
6. Immunotherapy with dendritic cells primed with an allogenic melanoma cell line in advanced metastatic melanoma.
Conclusions: From our observations, immunotherapy with dendritic cells primed with an allogeneic cell line may prolong the overall survival of patients with metastatic melanoma.
7. From the journal 'Nature': Dendritic cell vaccination for cancer therapy
http://www.nature.com/onc/journal/v19/n56/full/1204095a.html
8. From International Association of Oral and Maxillofacial Surgeons
Effect of dendritic cell vaccine against a tongue squamous cell cancer cell line (Tca8113) in vivo and in vitro
www.ncbi.nlm.nih.gov/pubmed/16503117
9. Murine renal cell carcinoma: evaluation of a dendritic-cell tumour vaccine.
http://www.ncbi.nlm.nih.gov/pubmed/11564033
CONCLUSION: These results show that it is possible to use the DC vaccine to modulate the immune response to achieve an antitumour effect, but further manipulation of the DC vaccine may be needed to overcome the tumour-induced immune suppression.
To get more information contact:
Dr Mohammad K Munir,
MBBS, MAGS . Consultant, Medlife Asia Hyderabad,
Ex Associate NPSP, WHO
Ex Consultant, Kamineni Wockhardt hospital, King Koti, Hyderabad.
Oncology expert panel member in Allexperts, About Inc., New York Times, USA.
Hony consultant, IAMMS (A UNESCO Listed organization)
MEDLIFE ASIA
Ph: 9603018957, 9959098255
Email: medlifeasia@gmail.com
For questions on cancer therapies or collaboration inquiries, feel free to contact us at the above email/phone numbers.
Feel free to contact us at medlifeasia@gmail.com